ArticlePregnancy (Hoboken, N.J.)2025
Clinical care team perspectives on universal low-dose aspirin in pregnancy.
Article in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess clinical care team perceptions of universal low-dose aspirin (LDA) in a prenatal care clinic serving patients of low socioeconomic status. Methods: This was a theory-based rigorous qualitative study of clinical care team members in an urban, tertiary care center prenatal clinic. Participants were recruited between April and July 2023 and participated in focus groups. Focus groups employed a semi-structured guide using the Consolidated Framework for Implementation Research (CFIR). Results: A total of 25 care team members met for 19-36 min, of which the majority ( Conclusion: Care team members serving prenatal patients of low socioeconomic status are open to universal prescription of LDA in pregnancy, though important barriers to provider and patient knowledge and workflow must be addressed to result in successful quality improvement initiatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.